Matthew A Cerny
5PUBLICATIONS
24CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 02, 2025
Design and application of synthetic 17B-HSD13 substrates reveals preserved catalytic activity of protective human variants.Michelle R Garnsey, Yang Wang, David J Edmonds
|Aug 07, 2024
The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans.Jonathan N Bauman, Angela C Doran, Gabrielle M Gualtieri
|Jul 30, 2021
Static and Dynamic Projections of Drug-Drug Interactions Caused by Cytochrome P450 3A Time-Dependent Inhibitors Measured in Human Liver Microsomes and Hepatocytes.Elaine Tseng, Heather Eng, Jian Lin
|Apr 03, 2021
Cytochrome P450 3A Time-Dependent Inhibition Assays Are Too Sensitive for Identification of Drugs Causing Clinically Significant Drug-Drug Interactions: A Comparison of Human Liver Microsomes and Hepatocytes and Definition of Boundaries for Inactivation Rate Constants.Heather Eng, Elaine Tseng, Matthew A Cerny
|Aug 03, 2018
Identification and Characterization of a Selective Human Carbonyl Reductase 1 Substrate.Diane Ramsden, Dustin Smith, Raquel Arenas
Pageof 1
Frequent Collaborators
3 joint publications
Heather Eng
2 joint publications
Theunis C Goosen
2 joint publications
R Scott Obach
1 joint publications
Dustin Smith
1 joint publications
Elaine Tseng
1 joint publications
Martin E Dowty
1 joint publications
Michelle R Garnsey
1 joint publications
Yang Wang
1 joint publications
David J Edmonds
1 joint publications
Matthew F Sammons
